title: Acute kidney injury following cardiac surgery: impact of early versus late haemofiltration on morbidity and mortality.
abstract: Various forms of renal replacement therapies (RRT) are available to treat acute kidney injury (AKI) after cardiac surgery. The objective of this review is to assess the incidence of postoperative AKI that necessitates the application of haemofiltration in adult patients undergoing cardiac operations with cardiopulmonary bypass (CPB), to determine the factors that influence the outcome in these patients. In addition, the review aims to assess the outcomes of postoperative early haemofiltration as compared to late intensive haemofiltration. Different forms of RRT such as intermittent haemodialysis, continuous haemofiltration, or hybrid forms which combine advantages of both are now available for application in cardiac surgery patients, and will be discussed in this article. The underlying disease, its severity and stage, the aetiology of AKI, clinical and haemodynamic status of the patient, the resources available, and different costs of therapy may all influence the choice of the RRT strategy. AKI, with its risk of uraemic complications, represents an independent risk factor for adverse outcomes in critically ill patients after cardiac surgery. Whether early initiation of RRT is associated with improved survival is unknown, and also clear guidelines on RRT durations are still lacking. In particular, it remains unclear whether haemodynamically unstable patients who develop septic shock pre- and postoperatively can benefit from early RRT initiation. In addition, it is not known whether in AKI patients undergoing cardiac surgery RRT modalities can eliminate significant amounts of clinically relevant inflammatory mediators. This review gives an update of information available in the literature on possible mechanisms underlying AKI and the recent developments in continuous renal replacement treatment modalities.
authors.affiliation: Wessex Cardiothoracic Centre, Institute of Developmental Sciences, General Hospital, Southampton, United Kingdom.
authors.forename: Maqsood
authors.initials: M
authors.lastname: Elahi
authors.forename: Sanjay
authors.initials: S
authors.lastname: Asopa
authors.forename: Axel
authors.initials: A
authors.lastname: Pflueger
authors.forename: Nadey
authors.initials: N
authors.lastname: Hakim
authors.forename: Bashir
authors.initials: B
authors.lastname: Matata
mesh_terms: D058186:Acute Kidney Injury / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D006440:Hemofiltration / Q000379:methods; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D011182:Postoperative Care / Q000379:methods; D017582:Renal Replacement Therapy / Q000379:methods*; D012307:Risk Factors
chemical_list: D018836:Inflammation Mediators